Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration-resistant Prostate Cancer

Explore clinical trials studying Metastatic Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

141 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration-resistant Prostate Cancer trial results

Active, Not Recruiting

ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC

NCT05682443

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Rocky Mountain Cancer Centers USOR Aurora, Colorado, United States
  • Moffitt Cancer Cancer Tampa, Florida, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

NCT06691984

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Providence Saint Jude Medical Center Fullerton, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 164 locations
View Trial Details
Active, Not Recruiting

A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer

NCT07553988

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • State Budgetary Healthcare Institution of the Arkhangelsk Region "Arkhangelsk Oncology Dispensary" Arkhangelsk, Russia
  • Moscow City Clinical Oncology Hospital No. 62 of the Moscow Department of Healthcare Istra, Russia
  • Ivanovo Regional Oncology Dispensary Ivanovo, Russia
  • Kaluga Regional Clinical Oncology Dispensary Kaluga, Russia
View all 16 locations
View Trial Details
Active, Not Recruiting

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

NCT05457257

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • Research Site Beijing, China
  • Research Site Bengbu, China
  • Research Site Changsha, China
  • Research Site Changsha, China
View all 35 locations
View Trial Details
Active, Not Recruiting

FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT06402331

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Hoag Health Center Irvine Irvine, California, United States
  • VA Greater Los Angeles Healthcare System Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 18 locations
View Trial Details

Related conditions